Download presentation
Presentation is loading. Please wait.
Published byHeikki Väänänen Modified over 6 years ago
1
Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo Eli O. Meltzer, MD, Claus Bachert, MD, PhD, Heribert Staudinger, MD Journal of Allergy and Clinical Immunology Volume 116, Issue 6, Pages (December 2005) DOI: /j.jaci Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions
2
Fig 1 Difference in mean MSS (averaged daily for am and pm assessments) over days 2 to 15. A, Active treatment groups compared with placebo. B, MFNS treatment groups compared with amoxicillin. Analyses are based on intent-to-treat population. BID, Twice daily; QD, once daily. Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci ) Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions
3
Fig 2 Change in MSS over time. Analyses are based on intent-to-treat population. BID, Twice daily. Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci ) Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.